Kreatech Biotechnology

Kreatech Biotechnology is a specialized life sciences company focused on the development of advanced labeling and detection reagents for molecular diagnostics. The company is renowned for its proprietary Universal Linkage System (ULS), a non-enzymatic technology that allows for the direct labeling of nucleic acids and proteins with various markers. Kreatech's primary product line consists of high-quality Fluorescence In Situ Hybridization (FISH) probes used to detect genetic aberrations in oncology and cytogenetics. In 2013, the company was acquired by Leica Biosystems, a division of Danaher Corporation, to integrate its molecular pathology tools into Leica's automated diagnostic platforms. Kreatech's innovations continue to support clinical laboratories in providing accurate genetic analysis for cancer and prenatal testing.